Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 102Head & Neck 67Thoracic 34Other solid neoplasm 14Tumor-Agnostic 7Gynecologic 6Breast 5Sarcoma 4Genitourinary 4Dermatologic 4CNS 4Myeloid 2Lymphoid 2Other neoplasm 1Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

venetoclax 309Cyclophosphamide 233Cytarabine 200Azacitidine 192fludarabine 182Specimen Handling 135Biopsy 103fludarabine phosphate 97Methotrexate 82Rituximab 80Daunorubicin 79Dexamethasone 76Vincristine 70Whole-Body Irradiation 65Mycophenolic Acid 60Decitabine 57Tacrolimus 55ibrutinib 52Etoposide 52blinatumomab 51obinutuzumab 50Granulocyte Colony-Stimulating Factor 50Busulfan 50Prednisone 48Melphalan 48acalabrutinib 47Injections 47Stem Cell Transplantation 45Magnetic Resonance Spectroscopy 43Idarubicin 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cetuximab × Other hematologic neoplasm × 1 year × Clear all
NCT06447987 2025-12-17

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Recruiting
24 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡